Highlights from the ADVENT educational symposium at EADV 2024 where Professors Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller explored the local and systemic effects of type 2 inflammation in AD and potential benefits of early intervention with regard to disease modification.
In this ADVENT symposium at the EADV 2024 conference in Amsterdam, Professors Eric Simpson, Stephan Weidinger, and Marjolein de Bruin-Weller explored the local and systemic effects of type 2 inflammation in AD, and the potential benefits of early intervention with regard to disease modification. Recent real-world data on the use of advanced systemic treatments for patients with AD was also presented.